These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20712774)

  • 1. Transcriptional silencing of fetal hemoglobin by BCL11A.
    Sankaran VG; Xu J; Orkin SH
    Ann N Y Acad Sci; 2010 Aug; 1202():64-8. PubMed ID: 20712774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.
    Sankaran VG; Menne TF; Xu J; Akie TE; Lettre G; Van Handel B; Mikkola HK; Hirschhorn JN; Cantor AB; Orkin SH
    Science; 2008 Dec; 322(5909):1839-42. PubMed ID: 19056937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding patterns of BCL11A in the globin and GATA1 loci and characterization of the BCL11A fetal hemoglobin locus.
    Jawaid K; Wahlberg K; Thein SL; Best S
    Blood Cells Mol Dis; 2010 Aug; 45(2):140-6. PubMed ID: 20542454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
    Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
    Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
    Neishabury M; Zamani F; Keyhani E; Azarkeivan A; Abedini SS; Eslami MS; Kakroodi ST; Vesiehsari MJ; Najmabadi H
    Blood Cells Mol Dis; 2013 Aug; 51(2):80-4. PubMed ID: 23541515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
    Bauer DE; Orkin SH
    Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
    Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
    Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch.
    Liu N; Hargreaves VV; Zhu Q; Kurland JV; Hong J; Kim W; Sher F; Macias-Trevino C; Rogers JM; Kurita R; Nakamura Y; Yuan GC; Bauer DE; Xu J; Bulyk ML; Orkin SH
    Cell; 2018 Apr; 173(2):430-442.e17. PubMed ID: 29606353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations.
    Basak A; Hancarova M; Ulirsch JC; Balci TB; Trkova M; Pelisek M; Vlckova M; Muzikova K; Cermak J; Trka J; Dyment DA; Orkin SH; Daly MJ; Sedlacek Z; Sankaran VG
    J Clin Invest; 2015 Jun; 125(6):2363-8. PubMed ID: 25938782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease.
    Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M
    Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional Repressor BCL11A in Erythroid Cells.
    Zheng G; Orkin SH
    Adv Exp Med Biol; 2024; 1459():199-215. PubMed ID: 39017845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the fetal hemoglobin silencing factor BCL11A.
    Basak A; Sankaran VG
    Ann N Y Acad Sci; 2016 Mar; 1368(1):25-30. PubMed ID: 26963603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal β-like globin genes.
    Roosjen M; McColl B; Kao B; Gearing LJ; Blewitt ME; Vadolas J
    FASEB J; 2014 Apr; 28(4):1610-20. PubMed ID: 24371119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches.
    Sripichai O; Fucharoen S
    Expert Rev Hematol; 2016 Dec; 9(12):1129-1137. PubMed ID: 27801605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific transcription of fetal genes in primary erythroid cell cultures from Lepore and deltabeta degrees thalassemia patients.
    Di Marzo R; Acuto S; Calzolari R; Maggio A
    Exp Hematol; 2005 Nov; 33(11):1363-70. PubMed ID: 16263421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
    Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
    Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.
    Xu J; Bauer DE; Kerenyi MA; Vo TD; Hou S; Hsu YJ; Yao H; Trowbridge JJ; Mandel G; Orkin SH
    Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6518-23. PubMed ID: 23576758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovering the genetics underlying foetal haemoglobin production in adults.
    Thein SL; Menzel S
    Br J Haematol; 2009 May; 145(4):455-67. PubMed ID: 19344402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between hemoglobin F levels and single nucleotide polymorphism at BCL11A gene rs11886868 locus in β-thalassemia patients].
    Chen QR; Sun SC; Peng YS; Wang Q; Mo BM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):650-3. PubMed ID: 22739175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-92a-3p-mediated inhibition of BCL11A upregulates γ-globin expression and inhibits oxidative stress and apoptosis in erythroid precursor cells.
    Li H; Lin R; Li H; Ou R; Wang K; Lin J; Li C
    Hematology; 2022 Dec; 27(1):1152-1162. PubMed ID: 36178486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.